Organigram Global Inc. Files May 2025 6-K Report

Ticker: OGI · Form: 6-K · Filed: May 5, 2025 · CIK: 1620737

Sentiment: neutral

Topics: reporting, foreign-private-issuer, regulatory-filing

Related Tickers: OGI

TL;DR

Organigram Global Inc. (OGI) filed its May 6-K, confirming Canadian operations and 40-F reporting.

AI Summary

Organigram Holdings Inc., now Organigram Global Inc., filed a Form 6-K on May 5, 2025, reporting for the month of May 2025. The company, incorporated in Canada with its principal executive offices in Toronto, Ontario, is a pharmaceutical preparations company. This filing indicates they are submitting their report under Form 40-F.

Why It Matters

This filing confirms Organigram Global Inc.'s reporting status and location, providing an update for investors tracking the company's regulatory submissions.

Risk Assessment

Risk Level: low — This is a routine filing confirming company information and reporting status, not indicating any new material events or risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2025.

What is the current name of the registrant?

The current name of the registrant is Organigram Global Inc.

What was the former name of the company?

The former company name was Organigram Holdings Inc.

Where are Organigram Global Inc.'s principal executive offices located?

The principal executive offices are located at 145 King Street West, Suite 1400, Toronto, Ontario, Canada M5H 1J8.

Under which form does the registrant file its annual reports?

The registrant indicates it files its annual reports under cover of Form 40-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding ORGANIGRAM GLOBAL INC. (OGI).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing